CYP cynata therapeutics limited

Ann: Investor Presentation, page-253

  1. 308 Posts.
    lightbulb Created with Sketch. 248
    There are problems to be solved industry wide, it's just that bone-marrow derived MSCs have a more significant one to solve. I know its frustrating for you to hear this again, but there is really no other way to chop it.

    I actually do not mind if we stick on the subject of safety, as it seems like an important debate.

    By way of evidence, CYP has always shown to be the more advanced technology that solves a significant issue in safety and commercialisation... and more.

    My money is and always wil be on CYP vs other cell companies/technologies.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.015(9.68%)
Mkt cap ! $38.41M
Open High Low Value Volume
15.5¢ 17.0¢ 15.5¢ $47.10K 289.1K

Buyers (Bids)

No. Vol. Price($)
1 50000 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 23813 3
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.